CardioMEMS™ HF System in Structural Heart: Integrated Heart Failure Care with PA Pressure Monitoring

© 2025 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Cath Lab Digest or HMP Global, their employees, and affiliates. 

Ryan K. Kaple, MD, FACC, FSCAI, is the Program Director of the Structural and Congenital Heart Program at Hackensack University Medical Center in Hackensack, New Jersey.

In this video, Dr. Kaple discusses how the CardioMEMS^™ HF System has become an essential tool in managing patients with chronic heart failure. By providing pulmonary artery pressure monitoring, the technology enables earlier identification of decompensation, often before symptoms occur, allowing clinicians to adjust therapy proactively and reduce heart failure hospitalizations. Dr. Kaple shares how integrating the CardioMEMS^™ HF System into his heart failure program has improved patient outcomes, optimized care coordination, and enhanced long-term quality of life for this high-risk population.

Sponsored by Abbott.

Listen to the full 34-minute video (below) or select from Chapters 1-5, located beneath the full video:

Individual Video Chapters:

Ch 1: Background & Clinical Rationale

• (0:20) To start, can you briefly explain what the CardioMEMS^™ HF System is and how it works?

• (1.27) Why is pulmonary artery pressure monitoring important in the management of heart failure, and how does the CardioMEMS^™ HF System address that need?  

Ch 2: Evidence

• (3:49) What have data shown regarding outcomes with the CardioMEMS^™ HF System? Can you address mortality and guideline-directed medical therapy (GDMT) optimization?  

Ch 3: CardioMEMS Program Value

• (8:20) How does incorporating the CardioMEMS^™ HF System for HF patient management affect program efficiency?

• (14:17) What clinical scenarios make the CardioMEMS^™ HF System a strategic tool in structural heart pathways?  

Ch 4: Clinical Workflows & Outcomes

• (20:19) How do you identify the right patients for the CardioMEMS^™ HF System within a structural heart workflow?

• (24:28) What role does the CardioMEMS^™ HF System play in reducing readmissions and optimizing GDMT in your practice?  

Ch 5: Patient, Physician, & Program Impact

• (26:24) Any final thoughts or key takeaways?

(end 34:26)